Cardinal Health, one of the largest drug wholesalers in the country, agreed to buy a rival, Bindley Western Industries, for $1.67 billion in stock. Cardinal will also assume $430 million in debt. Bindley shareholders will receive 0.4275 share of Cardinal for each Bindley share, equivalent to a 29 percent premium, based on Friday's closing prices. The deal gives Cardinal a position in the fast-growing business of selling radioactive diagnostic and treatment materials to hospitals and clinics. Shares of Cardinal fell $5.50, to $94; Bindley rose $5.88, to $38.88.
